CN104225344A - Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof - Google Patents
Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof Download PDFInfo
- Publication number
- CN104225344A CN104225344A CN201410540263.1A CN201410540263A CN104225344A CN 104225344 A CN104225344 A CN 104225344A CN 201410540263 A CN201410540263 A CN 201410540263A CN 104225344 A CN104225344 A CN 104225344A
- Authority
- CN
- China
- Prior art keywords
- weight
- preparation
- herba
- water
- smilacis glabrae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 62
- 230000001684 chronic effect Effects 0.000 title abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims description 98
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 57
- 206010037601 Pyelonephritis chronic Diseases 0.000 claims description 54
- 201000006368 chronic pyelonephritis Diseases 0.000 claims description 54
- 239000007788 liquid Substances 0.000 claims description 28
- 241000756943 Codonopsis Species 0.000 claims description 24
- 239000012567 medical material Substances 0.000 claims description 22
- 238000009835 boiling Methods 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 18
- 235000012907 honey Nutrition 0.000 claims description 12
- 239000006187 pill Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 244000025254 Cannabis sativa Species 0.000 abstract description 3
- 240000008867 Capsella bursa-pastoris Species 0.000 abstract description 2
- 240000001579 Cirsium arvense Species 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000011305 Capsella bursa pastoris Nutrition 0.000 abstract 1
- 235000005918 Cirsium arvense Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 description 19
- 210000002700 urine Anatomy 0.000 description 19
- 230000035619 diuresis Effects 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 230000027939 micturition Effects 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 229930182470 glycoside Natural products 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- -1 phenol glycoside Chemical class 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 208000008035 Back Pain Diseases 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 208000008930 Low Back Pain Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 6
- 210000003932 urinary bladder Anatomy 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 210000001624 hip Anatomy 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 208000019206 urinary tract infection Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 206010030302 Oliguria Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 3
- PCMORTLOPMLEFB-ONEGZZNKSA-N Sinapic acid Natural products COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 210000000244 kidney pelvis Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- 238000002562 urinalysis Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 2
- SYTGUXGLBXTALU-UHFFFAOYSA-N 2h-1,4-oxazine-3-carboxylic acid Chemical compound OC(=O)C1=NC=COC1 SYTGUXGLBXTALU-UHFFFAOYSA-N 0.000 description 2
- CJBDUOMQLFKVQC-UHFFFAOYSA-N 3-(2-hydroxyphenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=CC=C1O CJBDUOMQLFKVQC-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 description 2
- NESFDGDRYVANBC-UHFFFAOYSA-N 6-(hydroxymethyl)pyridin-3-ol Chemical compound OCC1=CC=C(O)C=N1 NESFDGDRYVANBC-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 2
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 2
- 208000037157 Azotemia Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010009168 Chyluria Diseases 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- XNVMKPYDOHZJLR-UHFFFAOYSA-N juncusol Chemical compound C1CC2=CC(O)=C(C)C(C=C)=C2C2=C1C(C)=C(O)C=C2 XNVMKPYDOHZJLR-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000012153 long-term therapy Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- JGHZJRVDZXSNKQ-UHFFFAOYSA-N methyl octanoate Chemical compound CCCCCCCC(=O)OC JGHZJRVDZXSNKQ-UHFFFAOYSA-N 0.000 description 2
- XIUXKAZJZFLLDQ-UHFFFAOYSA-N methyl pentadecanoate Chemical compound CCCCCCCCCCCCCCC(=O)OC XIUXKAZJZFLLDQ-UHFFFAOYSA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- KYSWLLSZOWOOGF-UHFFFAOYSA-N sorghumol Natural products O1C(=O)C(C)=CC1OC=C1C(=O)OC2C(C(C)(CO)CCC3)=C3CC21 KYSWLLSZOWOOGF-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 description 1
- FNUPUYFWZXZMIE-LSDHHAIUSA-N (2r,3r)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydrochromen-4-one Chemical compound C1([C@@H]2[C@H](C(C3=CC=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-LSDHHAIUSA-N 0.000 description 1
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 description 1
- YDZWHGJRWMQCDP-NKILCQAGSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2s,3r,4 Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YDZWHGJRWMQCDP-NKILCQAGSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- XWDAKKDQJHVMKG-LPJPOILFSA-N (8s,9s,10r,13r,14s,17r)-17-[(e,2r,5s)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 XWDAKKDQJHVMKG-LPJPOILFSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical class OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- WEPBGSIAWZTEJR-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-3-methoxyflavone Chemical compound O1C2=CC(O)=CC(O)=C2C(=O)C(OC)=C1C1=CC=C(O)C(O)=C1 WEPBGSIAWZTEJR-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- JSAKRLDIZOGQTN-UHFFFAOYSA-M 4-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate Chemical compound OC1=C(C2=CC=CC=C2C=C1)N=NC1=CC=C(C2=CC=CC=C12)S(=O)(=O)[O-] JSAKRLDIZOGQTN-UHFFFAOYSA-M 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- FBMORZZOJSDNRQ-UHFFFAOYSA-N Demethoxy,B,HCl-Adriamycin Natural products C1C2C(=C)CCCC2(C)CC2(O)C1=C(C)C(=O)O2 FBMORZZOJSDNRQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- VWYANPOOORUCFJ-YHEBVWOXSA-N Fernenol Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@@]4(C)[C@@H]5CC[C@H](C(C)C)[C@@]5(C)CC[C@]4(C)[C@H]3CC[C@H]21 VWYANPOOORUCFJ-YHEBVWOXSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- FNUPUYFWZXZMIE-UHFFFAOYSA-N Fustin Natural products O1C2=CC(O)=CC=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 FNUPUYFWZXZMIE-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- ZHPLPRUARZZBET-UHFFFAOYSA-N Gossypetin Natural products O1C2=C(O)C(O)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 ZHPLPRUARZZBET-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- ZPFXBGIJKDANBP-UHFFFAOYSA-N Hibiscetin Natural products OC1=C(O)C(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C(O)=C3O2)O)=C1 ZPFXBGIJKDANBP-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- VWYANPOOORUCFJ-MBVQSDBHSA-N Isoarborinol Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@H]5CC[C@@H](C(C)C)[C@]5(C)CC[C@@]4(C)[C@@H]3CC[C@H]21 VWYANPOOORUCFJ-MBVQSDBHSA-N 0.000 description 1
- RNHGVUKUAAZWMB-UHFFFAOYSA-N Isoarborinol Natural products CC(C)C1CCC2C1CCC3(C)C4CCC5C(C)(C)C(O)CCC5(C)C4=CCC23C RNHGVUKUAAZWMB-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000731961 Juncaceae Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029158 Nephroptosis Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000961970 Plantago depressa Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- XVXPXUMUGATHPD-JMJRLLIOSA-N Simiarenol Chemical compound C([C@@H]1[C@@]2(C)CC[C@@]3(C)[C@H]([C@@]2(CC[C@]11C)C)CC[C@@H]3C(C)C)C=C2[C@H]1CC[C@H](O)C2(C)C XVXPXUMUGATHPD-JMJRLLIOSA-N 0.000 description 1
- XVXPXUMUGATHPD-UHFFFAOYSA-N Simiarol Natural products CC(C)C1CCC(C2(CCC34C)C)C1(C)CCC2(C)C3CC=C1C4CCC(O)C1(C)C XVXPXUMUGATHPD-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- YWJGYBXHXATAQY-UHFFFAOYSA-N Taraxerylacetat Natural products C12CCC3(C)C4CC(C)(C)CCC4(C)CC=C3C1(C)CCC1C2(C)CCC(OC(=O)C)C1(C)C YWJGYBXHXATAQY-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- ZHDRLFGZQZCZKX-UHFFFAOYSA-N UNPD33269 Natural products CC1(C)CCCC2(C)C3=CCC4(C)C5CCC(C(C)C)C5(C)CCC4(C)C3CCC21 ZHDRLFGZQZCZKX-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047370 Vesicoureteric reflux Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- YWJGYBXHXATAQY-BOTWUFHUSA-N [(3s,4ar,6ar,6as,8ar,12ar,14ar,14br)-4,4,6a,6a,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl] acetate Chemical compound C([C@H]1[C@]2(C)CC[C@H]34)C(C)(C)CC[C@]1(C)CC=C2[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C YWJGYBXHXATAQY-BOTWUFHUSA-N 0.000 description 1
- OHLDETMXEXJUDZ-SYYHSBNDSA-N [(3s,8s,9s,10r,13r,14s,17r)-17-[(e,2r,5s)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] hexadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)\C=C\[C@@H](CC)C(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC)C1 OHLDETMXEXJUDZ-SYYHSBNDSA-N 0.000 description 1
- 235000009962 acacetin Nutrition 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 229940098166 bactrim Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 229960003716 cilastatin sodium Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- YRRAGUMVDQQZIY-UHFFFAOYSA-N gossypetin Chemical compound C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C(O)=C2O1 YRRAGUMVDQQZIY-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- CAOOISJXWZMLBN-PPHPATTJSA-N htn0d03vrz Chemical compound Cl.C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 CAOOISJXWZMLBN-PPHPATTJSA-N 0.000 description 1
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000002908 manganese Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N n-hexyl alcohol Natural products CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- YAWXLPDXHPHGPX-UHFFFAOYSA-N nona-2,4-dienoic acid Chemical class CCCCC=CC=CC(O)=O YAWXLPDXHPHGPX-UHFFFAOYSA-N 0.000 description 1
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 125000001792 phenanthrenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- RXHLADDBOLOIJO-UHFFFAOYSA-N quercetin 3-methyl ether Natural products COC1=C(Oc2c(O)cc(O)cc2C1=O)c3ccc(O)c(O)c3 RXHLADDBOLOIJO-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000837 restrainer Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- PKXVFQDVNGNKNY-IOIRRTEJSA-N stigmasterone Natural products CC[C@H](C=C[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C)C(C)C PKXVFQDVNGNKNY-IOIRRTEJSA-N 0.000 description 1
- OHLDETMXEXJUDZ-UHFFFAOYSA-N stigmasteryl palmitate Natural products C12CCC3(C)C(C(C)C=CC(CC)C(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCC)C2 OHLDETMXEXJUDZ-UHFFFAOYSA-N 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 239000008492 tangshen Substances 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- ZNMILUODKSYHAH-UHFFFAOYSA-N taraxeryl acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CCC4C5CC(C)(C)CCC5(C)CC=C34)C1(C)C ZNMILUODKSYHAH-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 1
- 229960003865 tazobactam Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal preparation for treating chronic nephropyelitis and a preparation method thereof. The preparation is prepared by using the following main raw materials by weight: 25-45 parts of rush, 5-12 parts of medical stone, 18-25 parts of plantain herb, 6-12 parts of codonopsis pilosula, 6-12 parts of rhizoma smilacis glabrae, 6-15 parts of field thistle, 20-40 parts of lalang grass rhizome, 15-25 parts of shepherd's purse, 15-25 parts of polygonum aviculare and 6-10 parts of ural licorice root tip. The Chinese herbal preparation is remarkable in effect, short in treatment course, free of tolerance and free of toxic and side effects. The chronic nephropyelitis is not prone to reappear after a patient is cured.
Description
Technical field
The present invention relates to traditional Chinese medicine field, particularly relate to a kind of Chinese medicine preparation and method for making thereof for the treatment of chronic pyelonephritis.
Background technology
Chronic pyelonephritis is the chronic inflammatory disease that bacteriological infection kidney causes, and pathological changes mainly invades renal interstitial and renal pelvis, renal calices tissue.Continue due to inflammation the infringement carrying out or repeatedly cause renal interstitial, renal pelvis, renal calices, form cicatrix, so that kidney generation atrophy and occur dysfunction.Patient may only have the soreness of waist and (or) low grade fever, can not have the dysurea of obvious urinary tract infection, frequent micturition and symptoms of urgency, and its main manifestations is that nocturia increases and has a small amount of leukocyte and albumen etc. in urinating.Patient has urinary tract infection medical history that is long-term or recurrent exerbation, can occur uremia late.Some patients has predisposing factor to exist, as urinary tract obstruction, deformity, nephroptosis and vesico-ureteric reflux etc.Clinical manifestation: 1. systemic toxicity profiles symptom.Fear of cold, heating, weak, inappetence.2. local symptom.The soreness of waist, lumbago and costovertebral angle kowtow pain.3. irritation sign of bladder.Frequent micturition, urgent micturition, dysurea and dysuria.And urinary tract infection medical history exceedes half a year more than, antibacterial therapy poor effect.
Urgent, chronic nephropyeltis all belongs to the traditional Chinese medical science " stranguria " category, so that women's sickness rate is the highest after marriage." stranguria " has dividing of pyretic stranguria, stranguria caused by urinary stone, stranguria with blood, stranguria marked by chyluria, stranguria caused by overstrain, but is classified as the large class of deficiency and excess two clinically more, and damp syndrome is based on damp and hot, and clearing away heat-damp and promoting diuresis is paid attention in treatment; Deficiency syndrome are suffered from a deficiency of the kidney based on spleen, and tonifying speen and tonifying kidney is worked as in treatment.Because primary disease is more obstinate, protracted inflammation, what have is for years on end, vigour of causing injury, and body resistance against diseases weakens unavoidably, and treatment often needs the long period.But concrete remedy measures, should note stage.When healthy energy is strengthened in the early stage, based on eliminating evil, the medicine of clearing away heat-damp and promoting diuresis should be taken, can prove effective very soon, more in addition strong agent is assisted, then can reach healing.Still exist to heresy in mid-term, just seeing and declining, heresy is just being divided and is being striven, eliminating evilly should hold concurrently with righting, see that how much heresy has, just hindering how much, to send on medicine should carefully respectively be looked after at prescription, administration schedule also should be considered proper, take heat-clearing and diuresis-promoting drug several days, after disease amelioration, take vital base and primordial QI consolidating agent again, be used alternatingly, treating both the principal and secondary aspects of a disease, disease is easy to cure.To the later stage, be short of physical strength, resistance against diseases decays, often easily acute attack, now measure, must guard against when showing effect, excessively emphasizing dampness removing heat clearing away, to dampen the vigour of only depositing.Should when showing effect, suitable is suppressed, and sees alleviation, namely throws the medicine of foster kidney qi, adhere to taking, if goodbye acute attack, still repeatedly treat with this side, disease-resistant function will be cumulative, the probability of recurrence reduces, and patient's condition alleviates gradually, until no longer recur, thoroughly fully recovers.Examine inspection is completely normal, must adhere to after treatment, and compatibility and incompatibility of drugs is tired, avoids wind and cold to cause flu, in case recurrence.2. 1. Therapeutic Principle selects sensitive bacteria to Drug therapy (1) and toxicity is less, and all has the antibiotic of higher concentration in excess of the kidney matter and urine; 2. comparatively long-term therapy (4 weeks or 6 weeks) is adopted, to reaching the object of thorough bacteria removal; 3. as can not bacteria removal and urinary tract infection acute attack repeatedly, the antimicrobial therapeutics of low dosage long-term therapy be adopted, at least medication more than 1 year; When 4. there is uremia, should renal function protecting be noted, avoid drug accumulation poisoning, again can bacteria growing inhibiting well.(2) selection of medicine.The lighter can with bactrim, quinolones or to add the semi-synthetic penbritin of beta lactamase restrainer oral, and severe one needs drug combination and intravenous administration, adds tazobactam or imipenum adds Cilastatin Sodium as piperacillin.3. drug safety.Avoid the medicine of kidney damage, such as: streptomycin, gentamycin, ionic contrast agent etc.
Application publication number CN 103041203 A(application number 201210565882.7) Chinese patent literature disclose one and treat chronic pyelonephritis Chinese medicine formula, mainly contain following component and make by weight ratio: major ingredient: Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, 18 grams, Poria, 18 grams, the Radix Rehmanniae, Cortex Moutan 9 grams, Rhizoma Alismatis 15 grams, Semen Cuscutae 24 grams, Semen Plantaginis 12 grams of Herba Polygoni Avicularis 15 grams, Herba Dianthi 15 grams, Flos Lonicerae 18 grams, Herba Leonuri 30 grams, Rhizoma Imperatae 30 grams, Radix Glycyrrhizae uralensis 9 grams, adjuvant: water 500mL.Application publication number CN 102370853 A(application number 201110327150.X) Chinese patent literature disclose a kind of Chinese medicine for the treatment of chronic pyelonephritis, it is characterized in that it is made up of the component of the material medicine proportioning of following weight: Radix Astragali 40-45g, Radix Angelicae Sinensis 20-25g, Radix Rehmanniae 30-35g, Fructus Corni 20-23g, Rhizoma Dioscoreae 20-23g, Cortex Moutan 10-12g, Poria 10-12g, Rhizoma Alismatis 10-12g, Radix Aconiti Lateralis Preparata 10-12g, Radix Sophorae Flavescentis 20-25g, Herba Patriniae 60-65g, Herba Taraxaci 60-65g, Herba Cirsii 30-35g, Herba Houttuyniae 30-35g, Radix Glycyrrhizae 10-12g.Application publication number CN 102614445 A(application number 201210039859.4) Chinese patent literature disclose a kind of Chinese medicine for the treatment of chronic pyelonephritis, it by Rhizoma Curculiginis, Radix Angelicae Sinensis, Fructus Amomi, Radix Morindae Officinalis, Rhizoma Alismatis, Herba Cirsii by certain part by weight array become.
Chronic pyelonephritis is more obstinate, and the course of disease is longer, and what have does not heal for many years.At present, use Western medicine as better for treatment chronic pyelonephritis curative effect in antibiotic, but life-time service antibiotic, antibacterial can produce drug resistance, or enters in cell, makes antibiotic lose sterilizing ability, easy recurrent exerbation, Chinese medicine can resist drug resistance, does not have toxic and side effects, but the Chinese medicine preparation curative effect for the treatment of chronic pyelonephritis is not obvious at present.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide a kind of Chinese medicine preparation for the treatment of chronic pyelonephritis and preparation method thereof.Be very effective of the present invention, short treating period, not easily recurs, and can not produce drug resistance, and have no side effect.
Technical scheme of the present invention is:
The Chinese medicine preparation for the treatment of chronic pyelonephritis, takes off the primary raw material medicine stating weight proportion and is prepared from: Medulla Junci 25-45, Maifanitum 5-12, Herba Plantaginis 18-25, Radix Codonopsis 6-12, Rhizoma Smilacis Glabrae 6-12, Herba Cirsii 6-15, Rhizoma Imperatae 20-40, Herba Capsellae 15-25 , Herba Polygoni Avicularis 15-25, Radix Glycyrrhizae uralensis 6-10.
The Chinese medicine preparation for the treatment of chronic pyelonephritis, preferred scheme is, takes off the primary raw material medicine stating weight proportion and is prepared from: Medulla Junci 28-40, Maifanitum 7-10, Herba Plantaginis 20-23, Radix Codonopsis 8-11, Rhizoma Smilacis Glabrae 7-10, Herba Cirsii 8-12, Rhizoma Imperatae 25-32, Herba Capsellae 17-22 , Herba Polygoni Avicularis 16-21, Radix Glycyrrhizae uralensis 7-9.
The Chinese medicine preparation for the treatment of chronic pyelonephritis, the scheme be more preferably is, takes off the primary raw material medicine stating weight proportion and is prepared from: Medulla Junci 34, Maifanitum 9, Herba Plantaginis 22, Radix Codonopsis 10, Rhizoma Smilacis Glabrae 8, Herba Cirsii 11, Rhizoma Imperatae 29, Herba Capsellae 20 , Herba Polygoni Avicularis 18, Radix Glycyrrhizae uralensis 8.
Present invention also offers the preparation method Chinese medicine preparation of aforementioned therapies chronic pyelonephritis being made pharmaceutically acceptable decoction, powder, thick paste agent and pill.
The preparation method of described decoction is:
(1) Rhizoma Smilacis Glabrae is first used the vexed 1-4 of water hour (preferably vexed 2.5 hours), the consumption of water is the consumption of the 1/25-1/8(preferred water of Rhizoma Smilacis Glabrae weight is 1/10 of Rhizoma Smilacis Glabrae weight), after use the vexed 2-5 of wine hour (preferably vexed 3 hours), the consumption of wine is the consumption of the preferred wine of 1/20-1/8(of Rhizoma Smilacis Glabrae weight is 1/7 of Rhizoma Smilacis Glabrae weight), dry;
(2) Maifanitum is smashed be placed in marmite, add the water (preferably adding the water of 2.5 times amount Maifanitum weight) of 2-5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 1-3 hour (preferably decocting 2 hours) afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water (preferably adding the water of medical material gross weight added by 3.5 times amount) of medical material gross weight added by 2.5-6 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.5-1.5 hour (preferably decocting 0.8 hour), leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water (preferably adding the water of 2.8 times amount medical material gross weights) of 2-5 times amount medical material gross weight, first boil to boiling with big fire, rear turn of little fire decocts 10-40 minute (preferably decocting 28 minutes), leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, obtain decoction.
The preparation method of described powder is:
(1) each crude drug is removed impurity, pulverize respectively and grind to form fine powder, cross 120-180 mesh sieve (preferred mistake 160 mesh sieve);
(2) step (1) gained fine powder is dropped into mixing and blending machine fully to mix, sterile packaged, often wrap 6 grams.
The preparation method of described thick paste agent is:
(1) Rhizoma Smilacis Glabrae is first used water moistening 1-4 hour (preferably vexed 2.5 hours), the consumption of water is the consumption of the 1/25-1/8(preferred water of Rhizoma Smilacis Glabrae weight is 1/10 of Rhizoma Smilacis Glabrae weight), after use the vexed 2-5 of wine hour (preferably vexed 3 hours), the consumption of wine is the consumption of the preferred wine of 1/20-1/8(of Rhizoma Smilacis Glabrae weight is 1/7 of Rhizoma Smilacis Glabrae weight), dry;
(2) Maifanitum is smashed be placed in marmite, add the water (preferably adding the water of 2.5 times amount Maifanitum weight) of 2-5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 1-3 hour (preferably decocting 2 hours) afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water (preferably adding the water of medical material gross weight added by 3.5 times amount) of medical material gross weight added by 2.5-6 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.5-1.5 hour (preferably decocting 0.8 hour), leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water (preferably adding the water of 2.8 times amount medical material gross weights) of 2-5 times amount medical material gross weight, first boil to boiling with big fire, rear turn of little fire decocts 10-40 minute (preferably decocting 28 minutes), leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, decompression, to be concentrated into relative density be the preferred relative density of 1.0-1.4(is 1.3) clear paste, then add adjuvant and mix well, seal and get final product in dress aseptic bottle.
The preparation method of described pill is:
(1) each crude drug is removed impurity, after drying, these medicines are mixed together and are ground into fine powder, 140-220 object sieve (preferably using 160 object sieves), mixing;
(2) refined honey is joined in step (1) gained fine powder, the weight of refined honey be the 1/2-1.2 of medicine gross weight doubly (weight of preferred refined honey is 0.8 times of medicine gross weight), make every ball weight be 0.1-0.4g(preferably every ball weight be 0.3g) small honey pill.
The pharmacology of the present invention's main raw material of Chinese medicine used is as follows:
Medulla Junci: base is former: be the dry stem pith of rush family plant Medulla Junci.Stem pith, containing multiple phenanthrene derivatives, has been separated and has obtained: Medulla Junci diphenol, 6-methyl Medulla Junci diphenol, juncusol, 2,6-dihydroxy-1,7-dimethyl-5-vinyl-9,10-dihydro is luxuriant and rich with fragrance, 2,7-dihydroxy-1,8-dimethyl-5-vinyl-9,10-dihydro is luxuriant and rich with fragrance, and 2,8-dihydroxy-1,6-dimethyl-5-vinyl-9,10-dihydro is luxuriant and rich with fragrance, 8-hydroxyl-2-methoxyl group-1,6-dimethyl-5-vinyl-9,10-dihydro is luxuriant and rich with fragrance.The property of medicine: sweet, light, is slightly cold.GUIXIN, lung, small intestine meridian.Function cures mainly: clearing away heart-fire, diuresis.For vexed insomnia, the puckery pain of oliguria, aphtha of the mouth and tongue.Modern study effect: there is anastalsis.Treatment Child epidemic parotitis, evident in efficacy.Control epistaxis, have effective.Also chronic glomerulonephritis can be treated, common cold of gastrointestinal type.Sore throat can be controlled.
Maifanitum: base is former: be Acid-intermediate igneous rock rocks beschtauite.Composition: Maifanitum main component has silicon dioxide, aluminium oxide, ferrum oxide, ferrous oxide, magnesium oxide, calcium oxide, sodium oxide, potassium oxide, titanium dioxide, phosphorus pentoxide, manganese oxide, carbon dioxide, and the trace element such as fluorine, sulfur, strontium, barium, copper, zinc.The property of medicine: " detailed outline ": " sweet, temperature, nontoxic." function cures mainly: removing toxic substances and promoting granulation, damp eliminating spleen invigorating.Cure mainly carbuncle carbuncle on the back, acne, eczema, beriberi, miliaria, finger is chapped, chloasma, toothache, oral ulcer, rheumatic arthralgia, lumbago and backache, chronic hepatitis, gastritis, dysentery, diabetes, neurasthenia, wound is red and swollen, hypertension, senile sclerosis of blood vessels, tumor, lithangiuria.Generally make health product.Compatibility and incompatibility of drugs: superfine end need be ground during external application, otherwise easily cause pain.
Herba Plantaginis: base is former: be the dry herb of Plantaginaceae plant Herba Plantaginis or Plantago depressa Willd.Herba Plantaginis herb contains ursolic acid, positive hentriacontane, cupreol, stigmasterol, β-paddy alcohol cetylate, stigmasteryl palmitate, aucubin, Herba Plantaginis glycosides A, B, C, D, E, F, remove rhamnose different Syring vulgaris phenol glycoside B, remove rhamnose Syring vulgaris phenol glycoside, different Syring vulgaris phenol glycoside, Syring vulgaris phenol glycoside, people from sky grass glycoside A, different unicorn glycoside, unicorn glycoside.The property of medicine: sweet, cold.Return liver, kidney, lung, small intestine meridian.Function cures mainly: clearing away heat and promoting diuresis, eliminates the phlegm, removing heat from blood, removing toxic substances.For edema oliguria, the puckery pain of pyretic stranguria, heat-damp in summer dysentery, phlegm-heat cough, hematemesis and epistaxis, carbuncle sore tumefacting virus.
Radix Codonopsis: base is former: be the dry root of Campanulaceae Radix Codonopsis, element flower Radix Codonopsis or radix codonpsis tangshen etc.Radix Codonopsis has containing sterols: hitodesterol, stigmasterol, hitodesterol-β-D-Glucose glycoside, stigmasterol-β-D-Glucose glycoside, α-Herba Spinaciae sterone, stigmasterone etc.Sugar and glycoside have: inulin, fructose, four kinds of heteropolysaccharide containing fructose.Syringin, β-D-Glucopyranose. hexanol glycoside, α-D-fructofuranose ethanol glycoside.Alkaloid and nitrogen containing component have: choline, normal-butyl allophanate, codopiloic acid, 5-hydroxy-2-hydroxymethylpyridine, nicotine.Volatile ingredient has: caproic acid, enanthic acid, sad, n-nonanoic acid, dodecoic acid, Azelaic Acid, tetradecylic acid, pentadecanoic acid, hexadecylic acid, stearic acid, octadecadienoic acid, 2,4-nonadienoic acids, Pentadecane, α-curcumene, n-heptadecane, n-octadecane, AI3-36122, positive 21 alkane, positive docosane, methyl myristate, pentadecanoic acid methyl ester, methyl palmitate, methyl stearate, octadecadienoic methyl, pinene, ethyl palmitate, methyl caprylate.Still containing triterpenes and other compositions: alnulin, Taraxeryl acetate, suberone; Atractyloide II, III; Syringic aldehyde, vanillic acid, 2-furan carboxylic esters, codonolactone, 5 hydroxymethyl furfural, 5-methoxyl group furfural.In addition, the also 17 seed amino acid property of medicine such as 14 kinds of inorganic elementss such as iron content, zinc, copper, manganese and aspartic acid, threonine, serine, glutamic acid: sweet, flat.Return spleen, lung meridian.Function cures mainly: invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency is coughed, and interior-heat is quenched one's thirst.
Rhizoma Smilacis Glabrae: base is former: be the rhizome of Liliaceae smilax plant smilacis glabra.Composition: rhizome is containing volatile oil: 49 kinds of compositions such as n-hexadecanoic methyl ester; Phenolic acids: 3-0-caffeoyl shikimic acid, ferulic acid; Steroidal saponin, flavonoid glycoside etc.The property of medicine: sweet, light, flat.Return liver,kidney,spleen, stomach warp.Function cures mainly: removing damp-heat, lets out turbid removing toxic substances, easing joint movement.Cure mainly syphilis, stranguria with turbid discharge, have loose bowels, muscles and bones spasm and pain, beriberi, carbuncle, skin ulcer tinea, scrofula, goiter and mercurialism.
Herba Cirsii: base is former: be aerial parts or the root of Compositae artichoke plant field thistle.Composition: wounded in the battle herb is containing flavone: rutin, linarin, i.e. robinin, that is acacetin-7-rhamnose glucoside, acacetin, apigenin, astragalin; Phenolic acids: protocatechuic acid, chlorogenic acid, caffeic acid; Sterols: taraxasterol etc.The property of medicine: sweet, micro-hardship, cool.Return liver, taste warp.Function cures mainly: cooling blood for hemostasis, removing toxic substances and promoting subsidence of swelling.Cure mainly hematuria, stranguria with blood, hemoptysis, spit blood, epistaxis, has blood in stool, dysentery, metrorrhagia and metrostaxis, traumatic hemorrhage, swollen ulcer drug.Rhizoma Imperatae: base is former: be the dry rhizome of grass Herba Imperatae.Chemical composition: rhizome Arundoin, Cylindrin, Coixol, fernenol, simiarenol, Isoarborinol, Anemonin; Also containing sterols: stigmasterol, cupreol, campesterol, saccharide, volume sucrose, glucose and a small amount of fructose, xylose; Simple acids: citric acid, oxalic acid and malic acid.The property of medicine: sweet, cold.Return lung, stomach, urinary bladder channel.Function cures mainly: cooling blood for hemostasis, clearing away heat and promoting diuresis.Spit blood for heat in blood, epistaxis, hematuria, calentura excessive thirst, jaundice, edema, the puckery pain of pyretic stranguria, acute nephritis edema.
Herba Capsellae: base is former: be the herb of Cruciferae shepherd's purse platymiscium Herba Capsellae.Composition: herb is containing flavonoid: dihydrofisetin, Quercetin-3-methyl ether, gossypetin pregnancy ether, diosmin etc.Fatty acid: Palmic acid, Fumaric acid, oxalic acid, tartaric acid, malic acid etc.Alkaloids: choline, acetylcholine, sinapic acid choline ester. etc.The property of medicine: sweet, light, cool.Return liver, spleen, urinary bladder channel.Function cures mainly: cool liver hemostasis, suppressing the hyperactive liver improving eyesight, clearing away heat-damp and promoting diuresis.Cure mainly haematemesis, epistaxis, spitting of blood, hematuria, metrorrhagia, conjunctival congestion and pain of eye, retinal hemorrhage, hypertension, dysentery, oedema due to nephritis, chyluria.
Herba Polygoni Avicularis: base is former: be the dry aerial parts of Liao section Zhi Wu Herba Polygoni Avicularis.Herb is containing flavones ingredient: Quercetin, avacularin, quercitrin, vitexin, isovitexin, luteolin, rhamnetin-3-half milk extract glycoside, hyperin etc.Also containing Coumarins composition: umbelliferone, scopoletin.Again containing acid ingredient: ferulic acid, sinapic acid, vanillic acid, syringic acid, melilotic acid, P-coumaric acid, P-hydroxybenzoic acid, gentisic acid, caffeic acid, protocatechuic acid, gallic acid, p-hydroxyphenylaceticacid, chlorogenic acid, salicylic acid, benzoaric acid, dextrorotation cachou extract, oxalic acid, silicic acid and methionine, proline, serine, threonine, tyrosine, phenylalanine, cystine, arginine, valine, glycine, leucine, lysine, isoleucine, tryptophan etc.Also containing glucose, fructose, sucrose, water soluble polysaccharide.The property of medicine: bitter, is slightly cold.Return urinary bladder channel.Function cures mainly: inducing diuresis for treating stranguria syndrome, and parasite killing is antipruritic.For bladder pyretic stranguria, oliguria with reddish urine, drenches the puckery pain of drop, skin eczema, pudendal pruritus leukorrhagia.
Radix Glycyrrhizae uralensis: base is former: be tip part or the radicula of the root of glycyrrhizic legume.Radix Glycyrrhizae root and rhizome, containing glycyrrhizin, is potassium, the calcium salt of glycyrrhizic acid.Still containing liquiritin, liquiritigenin, isoliquiritin, different Radix Glycyrrhizae unit, neoliquriitin, neoisoliquiritin etc.The property of medicine: sweet; Cold.GUIXIN, liver, spleen channel.Function cures mainly: eliminating fire and detoxication, inducing diuresis for treating stranguria syndrome.Main pyretic stranguria, oliguria, pain in penis, in the heart accumulated heat.
Chinese medicine preparation scientific formula provided by the invention, products obtained therefrom taking convenience.In addition, excellent results of the present invention also shows:
1, instant effect, curative effect is reliable;
2, can not drug resistance be produced, and have no side effect;
3, there is clearing away heat-damp and promoting diuresis, inducing diuresis for treating stranguria syndrome, removing toxic substances and promoting subsidence of swelling, invigorating the spleen and replenishing QI, the effects such as spleen invigorating lung benefiting, for treatment chronic pyelonephritis Be very effective;
4, cure rate is high, not easily recurs.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not limited thereto.
embodiment 1the Chinese medicine preparation for the treatment of chronic pyelonephritis, the primary raw material medicine getting following weight is prepared from: Medulla Junci 25g, Maifanitum 5g, Herba Plantaginis 18g, Radix Codonopsis 6g, Rhizoma Smilacis Glabrae 6g, Herba Cirsii 6g, Rhizoma Imperatae 20g, Herba Capsellae 15g, Herba Polygoni Avicularis 15g, Radix Glycyrrhizae uralensis 6g.
The preparation method of the Chinese medicine preparation decoction for the treatment of chronic pyelonephritis is:
(1) Rhizoma Smilacis Glabrae is first used vexed 1 hour of water, the consumption of water is 1/25 of Rhizoma Smilacis Glabrae weight, vexed 2 hours of rear wine,
The consumption of wine is 1/20 of Rhizoma Smilacis Glabrae weight, dries;
(2) Maifanitum is smashed be placed in marmite, add the water of 2 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 1 hour afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water of medical material gross weight added by 2.5 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.5 hour, leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water of 2 times amount medical material gross weights, first boil to boiling with big fire, rear turn of little fire decocts 10 minutes, leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, obtain decoction.
embodiment 2the Chinese medicine preparation for the treatment of chronic pyelonephritis, the primary raw material medicine getting following weight is prepared from: Medulla Junci 45g, Maifanitum 12g, Herba Plantaginis 25g, Radix Codonopsis 12g, Rhizoma Smilacis Glabrae 12g, Herba Cirsii 15g, Rhizoma Imperatae 40g, Herba Capsellae 25g, Herba Polygoni Avicularis 25g, Radix Glycyrrhizae uralensis 10g.
The preparation method of the Chinese medicine preparation powder for the treatment of chronic pyelonephritis is:
(1) each crude drug is removed impurity, pulverize respectively and grind to form fine powder, cross 160 mesh sieves;
(2) step (1) gained fine powder is dropped into mixing and blending machine fully to mix, sterile packaged, often wrap 6 grams.
model case one:zheng XX, female, 35 years old, December in 2012 first visit on the 22nd.Main suit: urgent micturition, dysurea about ten years repeatedly, increases the weight of 1 year.Medical history: Mrs's Zheng 5 years causes are suffered from cold and show trouble urgent micturition, dysurea, and disappear through curing performance, rear idol has outbreak, and attack times increased in nearly 1 year.Cause fatigue in four months, catch a cold and show frequent micturition, urgent micturition, dysurea, lower abdomen pendant pain, lumbago, beatting up element with cefalexin and Ao and cure and can control.Front upper disease bounce-back in two weeks, does not heal repeatedly.Existing the lumbago soreness of waist, sagging distention in the smaller abdomen cold type of pain, frequent micturition, urgent micturition, dysurea, the two lower limbs edema of trick, fear of cold is unable, white and slippery fur, deep and weak pulse.Albuminuria PRO+, urinary leukocyte 0-2/HP, midstream urine antibacterial culturing: bacterial population > 1 × 10
8bacterium number/L.Differential diagnosis in tcm: kidney yang deficiency, damp-heat in the urinary bladder.Western medicine diagnose: chronic pyelonephritis.Take the Chinese medicine preparation powder of the present embodiment gained treatment chronic pyelonephritis, every day twice, each 6g, boiled water is taken after mixing it with water.Take 5 days, the performance of urine urgency-frequency dysurea disappears, and lower abdomen pendant pain is not obvious, and lumbago alleviates, and trick and two lower limb still have Mild edema, thin white fur of tongue, deep-rolling pulse.Take 10 days, all transference cures, check routine urinalysis: albumen (-), leukocyte 0-1/HP, midstream urine antibacterial culturing is negative, recovery from illness.Follow up a case by regular visits to half a year not rebound.
embodiment 3the Chinese medicine preparation for the treatment of chronic pyelonephritis, the primary raw material medicine getting following weight is prepared from: Medulla Junci 28g, Maifanitum 7g, Herba Plantaginis 20g, Radix Codonopsis 8g, Rhizoma Smilacis Glabrae 7g, Herba Cirsii 8g, Rhizoma Imperatae 25g, Herba Capsellae 17g, Herba Polygoni Avicularis 16g, Radix Glycyrrhizae uralensis 7g.
The preparation method of the Chinese medicine preparation thick paste agent for the treatment of chronic pyelonephritis is:
(1) Rhizoma Smilacis Glabrae is first used vexed 2.5 hours of water, the consumption of water is 1/10 of Rhizoma Smilacis Glabrae weight, rear wine moistening 3 hours, and the consumption of wine is 1/7 of Rhizoma Smilacis Glabrae weight, dries;
(2) Maifanitum is smashed be placed in marmite, add the water of 2.5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 2 hours afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water of medical material gross weight added by 3.5 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.8 hour, leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water of 2.8 times amount medical material gross weights, first boil to boiling with big fire, rear turn of little fire decocts 28 minutes, leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, decompression, is concentrated into the clear paste that relative density is 1.3, then adds adjuvant and mix well, and seals and get final product in dress aseptic bottle.
model case two:king XX, female, 40 years old.After patient suffers from acute nephritis spring in 2009, recurrent exerbation, obstinate.Recently see again the dizzy soreness of waist, frequency of micturition difficulty is prohibited, and reaches more than 20 every day, and dark coloured urine is muddy, and Mental fatigue is drowsiness, anorexia, and after tired, above-mentioned all diseases are aggravated all the more, finally cause weak and limp from head to foot, almost can not walk.Then to be admitted to hospital diagnosis and treatment.Urine examination at that time: color cloud, leukocyte (+++), erythrocyte (++), albumen is a little, and epithelial cell is a little, is diagnosed as chronic pyelonephritis.Take the Chinese medicine preparation thick paste agent of the present embodiment gained treatment chronic pyelonephritis, every day three times, each 15 grams, warm water takes.After taking 6 days, patient mental take a turn for the better, appetite increase, total urination time comparatively before subtract greatly, arteries and veins turns mitigation.Take 15 days, urine examination: leukocyte (-), erythrocyte (-), albumen (-), does not find epithelial cell, clinical asymptomatic.Follow up a case by regular visits to and do not recur.
embodiment 4the Chinese medicine preparation for the treatment of chronic pyelonephritis, the primary raw material medicine getting following weight is prepared from: Medulla Junci 40g, Maifanitum 10g, Herba Plantaginis 23g, Radix Codonopsis 11g, Rhizoma Smilacis Glabrae 10g, Herba Cirsii 12g, Rhizoma Imperatae 32g, Herba Capsellae 22g, Herba Polygoni Avicularis 21g, Radix Glycyrrhizae uralensis 9g.
The preparation method of the Chinese medicine preparation pill for the treatment of chronic pyelonephritis is:
(1) each crude drug is removed impurity, after drying, these medicines are mixed together and are ground into fine powder, cross 160 mesh sieves, mixing;
(2) joined by refined honey in step (1) gained fine powder, the weight of refined honey is 0.8 times of medicine gross weight, and making every ball weight is the small honey pill of 0.3g.
model case three:pungent XX, female, 45 years old.Frequent micturition, urgent micturition, dysurea 10 years repeatedly, intermittent blepharoedema 3 years, paroxysmal lumbago companion nocturia increases 1 year, increases the weight of to be admitted to hospital for 10 days.Physical examination: blood pressure 158/106mmHg, two kidney percussion pain.Lab testing: urinary leukocyte (++), albumen (++), urine density 1.010, urine cultivates escherichia coli (Escherichia coli) growth, serum creatinine 470 μm of ol/L.Ultrasound diagnosis is shown: two kidney is asymmetric to be reduced, and distortion obviously.Be diagnosed as chronic pyelonephritis.Once with antibiotic and antimicrobial drug treatment, the state of an illness failed to control.Take the Chinese medicine preparation pill of the present embodiment gained treatment chronic pyelonephritis, every day three times, each 12, warm water takes.Take 3 days, blood pressure recovers normal, and symptom alleviates.Take 15 days, each index of urine examination recovers normal, and ultrasound diagnosis display is normal, recovery from illness.Follow up a case by regular visits to so far, have no recurrence.
embodiment 5the Chinese medicine preparation for the treatment of chronic pyelonephritis, the primary raw material medicine getting following weight is prepared from: Medulla Junci 34g, Maifanitum 9g, Herba Plantaginis 22g, Radix Codonopsis 10g, Rhizoma Smilacis Glabrae 8g, Herba Cirsii 11g, Rhizoma Imperatae 29g, Herba Capsellae 20g, Herba Polygoni Avicularis 18g, Radix Glycyrrhizae uralensis 8g.
The preparation method of the Chinese medicine preparation decoction for the treatment of chronic pyelonephritis is:
(1) Rhizoma Smilacis Glabrae is first used vexed 2.5 hours of water, the consumption of water is 1/10 of Rhizoma Smilacis Glabrae weight, vexed 3 hours of rear wine, and the consumption of wine is 1/7 of Rhizoma Smilacis Glabrae weight, dries;
(2) Maifanitum is smashed be placed in marmite, add the water of 2.5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 2 hours afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water of medical material gross weight added by 3.5 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.8 hour, leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water of 2.8 times amount medical material gross weights, first boil to boiling with big fire, rear turn of little fire decocts 28 minutes, leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, obtain decoction.
test example 1the clinical practice of Chinese medicine preparation decoction of embodiment 5 gained treatment chronic pyelonephritis: in August, 2009 in December ,-2011, screen 288 routine chronic pyelonephritis patients in 8 hospitals, be divided into two groups at random, treatment group and matched group.Treatment group 144 example, male 58 example, women 86 example, age 30-58 year, average 42.3 years old, course of disease 1.5-13, average course of disease 7.2 years.Matched group 144 example, male 57 example, women 87 example, age 32-59 year, average 43.4 years old, course of disease 1.5-13, average course of disease 7.5 years.Between two groups of patients, the aspect such as sex, age, course of disease compares, and no significant difference (P > 0.05), has comparability.Treatment group takes embodiment 5 products obtained therefrom, and instructions of taking is: take every day twice (warm), each 300mL.Matched group uses the conventional medication (as cephalosporin, carbenicillin, amoxicillin, levofloxacin hydrochloride and sodium chloride injection etc.) of other treatment chronic pyelonephritis.
Diagnostic criteria
The chronic pyelonephritis diagnostic criteria that the diagnostic criteria of chronic pyelonephritis is passed through with reference to the academic conference of Second China National nephropathy and " internal medicine " (5 editions) chronic pyelonephritis diagnostic criteria: 1. regular CCMS bacteria quantified cultivates clump count>=10
5/ mL; Clean centrifugal midstream urine sediment leukocyte>=10/HP; 2. urinary tract infection medical history > 6 months, in frequent outbreak 6 months>=2 times or 1 year in>=3 times; 3. X-ray intravenous urography is shown: renal pelvis renal calices distortion constriction; 4. soreness of waist pain, fatigue and weakness, dripping urination, sagging distention in the smaller abdomen, meets labor and originator.Meet and 1. 2. 4. or 1. 3. 4. get final product diagnosing chronic pyelonephritis.
Efficacy assessment standard
Criterion of therapeutical effect according to " new Chinese medicine guideline of clinical investigations " is drafted.Clinical cure: clinical symptoms, sign disappear, routine urianlysis twice is all normal, and urine bacterium is negative, and is feminine gender in 2-6 week check urine bacterium; Effective: clinical symptoms, sign disappear or substantially disappear, routine urinalysis is normal or close to normal, urine bacterium is negative; Effective: clinical symptoms, sign alleviate, and routine urinalysis significantly improves, urine bacterium is cultivated has the positive once in a while; Invalid: symptom and urine examination improve not obvious, the quantitative check of urine bacterium is still positive, or 2-6 week check urine bacterium is positive.Total effectively comprising cures and effective.Treat the effect after 14 days as shown in table 1.
Table 1: take embodiment 5 product chronic pyelonephritis patient treatment outcome
Effect: treatment group recovery from illness 103 example, total effective rate is 97.92%, and matched group recovery from illness 50 example, total effective rate is 64.58%, and treatment group is obviously better than matched group.Experiment shows, compared with using the conventional medication of other treatment chronic pyelonephritis, uses the cure rate of the Chinese medicine preparation of embodiment 5 gained treatment chronic pyelonephritis significantly to promote, and and inefficiency significantly reduce, curative effect is greatly improved.
The present invention selects Medulla Junci, Maifanitum, Herba Plantaginis etc. to carry out compatibility, produces synergism after making these drug regimens, for treatment chronic pyelonephritis Be very effective.Medulla Junci clearing away heart-fire in side, diuresis.Maifanitum removing toxic substances and promoting granulation, damp eliminating spleen invigorating.Herba Plantaginis clearing away heat and promoting diuresis, eliminates the phlegm, removing heat from blood, removing toxic substances.Radix Codonopsis invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.Rhizoma Smilacis Glabrae detoxifies, dehumidifying, sharp joint.Herba Cirsii cooling blood for hemostasis, removing toxic substances and promoting subsidence of swelling.Rhizoma Imperatae cooling blood for hemostasis, clearing away heat and promoting diuresis.The cool liver hemostasis of Herba Capsellae, suppressing the hyperactive liver improving eyesight, clearing away heat-damp and promoting diuresis.Herba Polygoni Avicularis inducing diuresis for treating stranguria syndrome, parasite killing, antipruritic.Radix Glycyrrhizae uralensis eliminating fire and detoxication, inducing diuresis for treating stranguria syndrome.All medicines share, and have clearing away heat-damp and promoting diuresis, inducing diuresis for treating stranguria syndrome, removing toxic substances and promoting subsidence of swelling, invigorating the spleen and replenishing QI, the effects such as spleen invigorating lung benefiting.The present invention has good effect, short treating period, advantage that cure rate is high to treatment chronic pyelonephritis, and has no side effect.
Finally it should be noted that, embodiment is the detailed description of the invention of optimum of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. treat the Chinese medicine preparation of chronic pyelonephritis, it is characterized in that, take off the primary raw material medicine stating weight proportion and be prepared from: Medulla Junci 25-45, Maifanitum 5-12, Herba Plantaginis 18-25, Radix Codonopsis 6-12, Rhizoma Smilacis Glabrae 6-12, Herba Cirsii 6-15, Rhizoma Imperatae 20-40, Herba Capsellae 15-25 , Herba Polygoni Avicularis 15-25, Radix Glycyrrhizae uralensis 6-10.
2. the Chinese medicine preparation for the treatment of chronic pyelonephritis according to claim 1, it is characterized in that, take off the primary raw material medicine stating weight proportion and be prepared from: Medulla Junci 28-40, Maifanitum 7-10, Herba Plantaginis 20-23, Radix Codonopsis 8-11, Rhizoma Smilacis Glabrae 7-10, Herba Cirsii 8-12, Rhizoma Imperatae 25-32, Herba Capsellae 17-22 , Herba Polygoni Avicularis 16-21, Radix Glycyrrhizae uralensis 7-9.
3. the Chinese medicine preparation for the treatment of chronic pyelonephritis according to claim 1, is characterized in that, takes off the primary raw material medicine stating weight proportion and is prepared from: Medulla Junci 34, Maifanitum 9, Herba Plantaginis 22, Radix Codonopsis 10, Rhizoma Smilacis Glabrae 8, Herba Cirsii 11, Rhizoma Imperatae 29, Herba Capsellae 20 , Herba Polygoni Avicularis 18, Radix Glycyrrhizae uralensis 8.
4. the Chinese medicine preparation of the treatment chronic pyelonephritis as described in as arbitrary in claim 1-3, is characterized in that, the Chinese medicine preparation of this treatment chronic pyelonephritis is made pharmaceutically acceptable decoction, powder, thick paste agent and pill.
5. the preparation method of the Chinese medicine preparation for the treatment of chronic pyelonephritis as claimed in claim 4, it is characterized in that, the preparation method of described decoction is:
(1) Rhizoma Smilacis Glabrae is first used the vexed 1-4 of water hour (preferably vexed 2.5 hours), the consumption of water is the consumption of the 1/25-1/8(preferred water of Rhizoma Smilacis Glabrae weight is 1/10 of Rhizoma Smilacis Glabrae weight), after use the vexed 2-5 of wine hour (preferably vexed 3 hours), the consumption of wine is the consumption of the preferred wine of 1/20-1/8(of Rhizoma Smilacis Glabrae weight is 1/7 of Rhizoma Smilacis Glabrae weight), dry;
(2) Maifanitum is smashed be placed in marmite, add the water (preferably adding the water of 2.5 times amount Maifanitum weight) of 2-5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 1-3 hour (preferably decocting 2 hours) afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water (preferably adding the water of medical material gross weight added by 3.5 times amount) of medical material gross weight added by 2.5-6 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.5-1.5 hour (preferably decocting 0.8 hour), leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water (preferably adding the water of 2.8 times amount medical material gross weights) of 2-5 times amount medical material gross weight, first boil to boiling with big fire, rear turn of little fire decocts 10-40 minute (preferably decocting 28 minutes), leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, obtain decoction.
6. the preparation method of the Chinese medicine preparation for the treatment of chronic pyelonephritis as claimed in claim 4, it is characterized in that, the preparation method of described powder is:
(1) each crude drug is removed impurity, pulverize respectively and grind to form fine powder, cross 120-180 mesh sieve (preferred mistake 160 mesh sieve);
(2) step (1) gained fine powder is dropped into mixing and blending machine fully to mix, sterile packaged, often wrap 6 grams.
7. the preparation method of the Chinese medicine preparation for the treatment of chronic pyelonephritis as claimed in claim 4, it is characterized in that, the preparation method of described thick paste agent is:
(1) Rhizoma Smilacis Glabrae is first used water moistening 1-4 hour (preferably vexed 2.5 hours), the consumption of water is the consumption of the 1/25-1/8(preferred water of Rhizoma Smilacis Glabrae weight is 1/10 of Rhizoma Smilacis Glabrae weight), after use the vexed 2-5 of wine hour (preferably vexed 3 hours), the consumption of wine is the consumption of the preferred wine of 1/20-1/8(of Rhizoma Smilacis Glabrae weight is 1/7 of Rhizoma Smilacis Glabrae weight), dry;
(2) Maifanitum is smashed be placed in marmite, add the water (preferably adding the water of 2.5 times amount Maifanitum weight) of 2-5 times amount Maifanitum weight, first boil to boiling with big fire, turn little fire and decoct 1-3 hour (preferably decocting 2 hours) afterwards, leach medicinal liquid;
(3) Herba Plantaginis is first installed with gauze bag, then join in above-mentioned marmite with step (1) gained Rhizoma Smilacis Glabrae and Radix Codonopsis, Herba Cirsii, Rhizoma Imperatae, Herba Polygoni Avicularis, Radix Glycyrrhizae uralensis, add the water (preferably adding the water of medical material gross weight added by 3.5 times amount) of medical material gross weight added by 2.5-6 times amount, first boil to boiling with big fire, rear turn of little fire decocts 0.5-1.5 hour (preferably decocting 0.8 hour), leaches medicinal liquid;
(4) Medulla Junci and Herba Capsellae are joined in above-mentioned marmite, add the water (preferably adding the water of 2.8 times amount medical material gross weights) of 2-5 times amount medical material gross weight, first boil to boiling with big fire, rear turn of little fire decocts 10-40 minute (preferably decocting 28 minutes), leaches medicinal liquid;
(5) step (2), step (3) and step (4) gained medicinal liquid are merged, decompression, being concentrated into relative density is that to be preferably concentrated into relative density be 1.3 to 1.0-1.4() clear paste, then add adjuvant and mix well, seal and get final product in dress aseptic bottle.
8. the preparation method of the Chinese medicine preparation for the treatment of chronic pyelonephritis as claimed in claim 4, it is characterized in that, the preparation method of described pill is:
(1) each crude drug is removed impurity, after drying, these medicines be mixed together and be ground into fine powder, sieving, mixing;
(2) joined by refined honey in step (1) gained fine powder, the weight of refined honey is 1/2-1.2 times (weight of preferred refined honey is 0.8 times of medicine gross weight) of medicine gross weight, makes small honey pill.
9. the preparation method of the Chinese medicine preparation pill for the treatment of chronic pyelonephritis as claimed in claim 8, is characterized in that, with 140-220 object sieve (preferably using 160 object sieve).
10. the preparation method of the Chinese medicine preparation pill for the treatment of chronic pyelonephritis as claimed in claim 8, is characterized in that, the weight of the every ball of the small honey pill made is the weight of the preferred every ball of 0.1-0.4g(is 0.3g).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410540263.1A CN104225344A (en) | 2014-10-14 | 2014-10-14 | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410540263.1A CN104225344A (en) | 2014-10-14 | 2014-10-14 | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104225344A true CN104225344A (en) | 2014-12-24 |
Family
ID=52214820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410540263.1A Pending CN104225344A (en) | 2014-10-14 | 2014-10-14 | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104225344A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687531A (en) * | 2016-02-29 | 2016-06-22 | 张向华 | Medicine for treating pyelonephritis |
| CN105687548A (en) * | 2016-04-13 | 2016-06-22 | 刘海强 | Chronic nephritis treating medicine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451396A (en) * | 2010-10-27 | 2012-05-16 | 赵传利 | Traditional Chinese medicine formula for treating acute pyelonephritis |
| CN103041203A (en) * | 2012-12-23 | 2013-04-17 | 徐化利 | Traditional Chinese medicine formula for treating chronic pyelonephritis |
-
2014
- 2014-10-14 CN CN201410540263.1A patent/CN104225344A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102451396A (en) * | 2010-10-27 | 2012-05-16 | 赵传利 | Traditional Chinese medicine formula for treating acute pyelonephritis |
| CN103041203A (en) * | 2012-12-23 | 2013-04-17 | 徐化利 | Traditional Chinese medicine formula for treating chronic pyelonephritis |
Non-Patent Citations (3)
| Title |
|---|
| 徐景芳: "清热通淋法治疗尿路感染103例疗效观察", 《中医杂志》 * |
| 曹田梅: "自拟清尿饮治疗老年尿路感染53例", 《中国中西医结合肾病杂志》 * |
| 韩寿清: "解毒通淋汤治疗急性肾盂肾炎92例", 《陕西中医》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105687531A (en) * | 2016-02-29 | 2016-06-22 | 张向华 | Medicine for treating pyelonephritis |
| CN105687548A (en) * | 2016-04-13 | 2016-06-22 | 刘海强 | Chronic nephritis treating medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104208245A (en) | Traditional Chinese medicine medicated bath for tinea of feet and hands and preparation method thereof | |
| CN104225344A (en) | Chinese herbal preparation for treating chronic nephropyelitis and preparation method thereof | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN104523872A (en) | Traditional Chinese medicine combination for treating rheumatic arthritis and preparation method thereof | |
| CN104491529A (en) | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof | |
| CN103845580A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN102641424B (en) | Chinese prepared medicine mixture for treating acute urticaria | |
| CN107213360A (en) | A kind of Chinese medicine composition for treating heavy myasthenia | |
| CN105106591A (en) | Bovine pulmonary edema treatment medicine and preparation method thereof | |
| CN104758701A (en) | Medicament for nursing treatment of stomach stones after lithotripsy and preparation method of medicament | |
| CN102631648A (en) | Chinese patent medicine for treating acute urticaria | |
| CN103127352B (en) | Chinese medicine composition for treating blood stasis type irregular menstruation | |
| CN104491206A (en) | Traditional Chinese medicine preparation for treating calculus of bile duct and preparation method thereof | |
| CN104622983A (en) | Traditional Chinese medicine composition for treating proctitis and preparation method thereof | |
| CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
| CN105434793A (en) | Composition for treating psoriasis pustulose and preparation method for composition | |
| CN103860976A (en) | Drug composition for treating infantile dermatitis | |
| CN104623247A (en) | Traditional Chinese medicine preparation for treatment of chronic enteritis | |
| CN104225342A (en) | Chinese herbal preparation for treating nephritis edema and preparation method thereof | |
| CN104225094A (en) | Traditional Chinese medicine preparation for treating Behcet's syndrome | |
| CN106310018A (en) | Traditional Chinese medicine composition for preventing and treating eczema and preparation method thereof | |
| CN105434844A (en) | Oral administration drug capable of effectively treating asthma and preparation method thereof | |
| CN105267742A (en) | Traditional Chinese medicine preparation for preventing and treating chronic renal failure and preparing method thereof | |
| CN105012549A (en) | Preparation for treating cystitis and preparation method | |
| CN104771684A (en) | Bath agent capable of treating menstrual disorder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 650000, building 13, Yunshan District, 57 Longhua Road, Panlong District, Yunnan, Kunming, 2-502 Applicant after: Duan Yongsheng Address before: 1 Zijinshan District, Zijin Mountain Road, Tianqiao District, Shandong, Ji'nan 250000, China Applicant before: Duan Yongsheng |
|
| COR | Change of bibliographic data | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |
|
| RJ01 | Rejection of invention patent application after publication |